Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01966874 · ClinicalTrials.gov registry record
Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days Gestation
A clinical trial, sponsored by Gynuity Health Projects.
- Completed
- Registry status
- 1,001
- Enrollment target
NCT01966874: Completed study, sponsored by Gynuity Health Projects.
NCT01966874 is a clinical trial that has completed, run by Gynuity Health Projects. The registered enrollment target is 1,001 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01966874 has completed, sponsored by Gynuity Health Projects.
- COMPLETED
- Registry status
- 1,001 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the efficacy and acceptability of a regimen of 200 mg mifepristone (Zacafemyl), followed 24-48 hours later by 800 mcg of buccal misoprostol.
Primary Outcome
Was the method effective in terminating pregnancy? This will be determined by the need for surgical intervention and the dose of misoprostol required.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,001 participants |
| Start Date | 2011-08 |
| Est. Completion | 2012-05 |
What the finished NCT01966874 record still lists
NCT01966874 is an observational study that tracks outcomes without assigning an intervention. Its 1,001 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01966874 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01966874 about?
NCT01966874 is a clinical study titled "Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days Gestation". The purpose of this study is to determine the efficacy and acceptability of a regimen of 200 mg mifepristone (Zacafemyl), followed 24-48 hours later by 800 mcg of buccal misoprostol.
What is the current status of trial NCT01966874?
This trial is currently completed. The enrollment target is 1,001 participants. The study started on 2011-08. Estimated completion is 2012-05.
Who is sponsoring clinical trial NCT01966874?
This trial is sponsored by Gynuity Health Projects, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06207864 · 1,001 participants · NA
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia